Chimney technique for type B aortic dissection

Original title: The Single-centre Experience of the Supra-arch Chimney Technique in Endovascular Repair of Type B Aortic Dissections. Reference: Y. Zhu et al. European Journal of Vascular and Endovascular Surgery Volume 45 Issue 6 June/2013.

Endovascular repair of type B aortic dissection (TEVAR) involving the arch, requires special techniques to preserve supra aortic vessels as fenestrated prostheses or stents in Chimney.

The chimney technique was originally described to treat abdominal aortic aneurysms but can also be used in the thoracic aorta. This study represents one of the largest series with this technique in the context of type B aortic dissection. Between 2006 and 2011 thoracic aorta was treated using endovascular techniques in 338 patients in a facility, of which 34 used the Chimney technique to protect supra aortic vessels, (3 brachiocephalic trunks, 8 left carotid and 23 left subclavian). The reason for using this technique was a proximal anchor point less than 15 mm with high surgical risk that contradicted a conventional or hybrid approach. 

Technical success was 82%, (28/34), showing a 15% (5/34) of type 1 leak immediate that decreased (n = 3) or disappeared (n = 2) after re-dilate or the implant of another stent. None of these leaks were observed in the follow-up CT scan within 3 months. There were no deaths or strokes peri procedure and after one year no aortic-related death was observed.

Conclusion:

Endovascular repair of thoracic aorta with the Chimney technique to preserve supra aortic vessels is a minimally invasive option with good medium-term results in patients with type B dissection discarded from surgery.

Editorial Comment:

This technique adds one more option for these high-risk patients. Historically, once discarded from surgery, there was only good control of blood pressure on offer. We can use covered stents as well as self-expanding stents or an expandable balloon for the chimneys, although the latter seem more desirable as their larger radial force prevents them from being compressed by the stent.

SOLACI.ORG

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...